Testosterone Science

In The News

Prescribing, access and cost

Incomplete reporting

Published Reported

Testosterone in men Heart and cardiovascular safety FDA, regulation and guidelines Prescribing, access and cost

Marius Pharmaceuticals applauds FDA’s proposed testosterone labeling updates as a turning point for men’s health

A cardiovascular outcomes trial of more than 5,200 men found no meaningful increase in major adverse cardiovascular events, and testosterone deficiency is a widespread, undertreated condition.

Read More

Not supported by research

Published Reported

Testosterone in men Fertility and sperm production Prescribing, access and cost Testosterone therapy: benefits and risks

11 Million Men on TRT: Why America’s Testosterone Revolution Is Just Getting Started

Average male testosterone has declined about 1% per year for decades, so that a 30-year-old today may have the testosterone level of his grandfather at age 50; enclomiphene is offered as an 'Oral Testosterone...

Read More

Accurate reporting

Published Reported

Testosterone in men Fertility and sperm production Prescribing, access and cost Testosterone therapy: benefits and risks

How Titan TRT works in 2026: labs, clinician consultation, medication, cost, and what men should know before starting

Symptoms alone are not enough to diagnose low testosterone, hematocrit above 54% is a contraindication, testosterone can suppress LH and FSH and impair fertility, and compounded testosterone and enclomiphene are not...

Read More

Shared decision making

Bring the evidence to your next consultation

Use our patient resources and questionnaires to prepare questions about symptoms, testing and treatment options for your doctor.